-
Caribou Biosciences NASDAQ:CRBU
Location: | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-60.46M
Cash
261.6M
Avg Qtr Burn
-30.06M
Short % of Float
14.14%
Insider Ownership
10.03%
Institutional Own.
63.10%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CB-012 Details Acute myeloid leukemia, Cancer | Phase 1 Data readout | |
CB-010 Details Non-Hodgkin lymphoma, Cancer, Blood cancer | Phase 1 Data readout | |
CB-011 Details Cancer, Blood cancer, Multiple myeloma | Phase 1 Data readout | |
CB-010 Details Lupus nephritis, Extrarenal lupus | Phase 1 Initiation |